Plasma Aβ42/Aβ40 determined by mass spectrometry is associated with longitudinal changes in amyloid accumulation, brain atrophy, and conversion to mild cognitive impairment due to Alzheimer's disease in individuals with subjective cognitive decline: 5-year follow-up of the FACEHBI cohort.

J Prev Alzheimers Dis · 2026 · PMC12988367 · PMID 41513583

Europe PMC DOI

hedged sentence

0.0720

closest p · 1.4× alpha

0.0720

boldest claim

The sentences

showed a trendP = 0.072so close (0.05 < p ≤ 0.1)

However, MMSE and Memory Composite S-FNAME-Occupations showed a trend ( P = 0.072 and P = 0.101, respectively).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.